nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP1A2—Carmustine—brain cancer	0.141	0.297	CbGbCtD
Bromazepam—CYP3A4—Temozolomide—brain cancer	0.107	0.225	CbGbCtD
Bromazepam—CYP3A4—Lomustine—brain cancer	0.0906	0.191	CbGbCtD
Bromazepam—CYP2E1—Etoposide—brain cancer	0.0722	0.152	CbGbCtD
Bromazepam—CYP1A2—Etoposide—brain cancer	0.0418	0.0881	CbGbCtD
Bromazepam—CYP3A4—Etoposide—brain cancer	0.0219	0.0462	CbGbCtD
Bromazepam—GABRG1—ganglion—brain cancer	0.00942	0.0338	CbGeAlD
Bromazepam—GABRA6—hindbrain—brain cancer	0.00711	0.0255	CbGeAlD
Bromazepam—Digestion impaired—Hydroxyurea—brain cancer	0.00636	0.0277	CcSEcCtD
Bromazepam—GABRA2—ganglion—brain cancer	0.0063	0.0226	CbGeAlD
Bromazepam—Ataxia—Lomustine—brain cancer	0.00591	0.0257	CcSEcCtD
Bromazepam—Nightmare—Procarbazine—brain cancer	0.00531	0.0231	CcSEcCtD
Bromazepam—GABRB2—hindbrain—brain cancer	0.00523	0.0188	CbGeAlD
Bromazepam—GABRQ—telencephalon—brain cancer	0.00521	0.0187	CbGeAlD
Bromazepam—Digestion impaired—Temozolomide—brain cancer	0.00497	0.0216	CcSEcCtD
Bromazepam—GABRA2—hindbrain—brain cancer	0.00478	0.0172	CbGeAlD
Bromazepam—GABRA1—hindbrain—brain cancer	0.00462	0.0166	CbGeAlD
Bromazepam—GABRA6—brainstem—brain cancer	0.00407	0.0146	CbGeAlD
Bromazepam—Speech disorder—Carmustine—brain cancer	0.004	0.0174	CcSEcCtD
Bromazepam—Diplopia—Procarbazine—brain cancer	0.00399	0.0174	CcSEcCtD
Bromazepam—Speech disorder—Temozolomide—brain cancer	0.00386	0.0168	CcSEcCtD
Bromazepam—GABRD—telencephalon—brain cancer	0.00378	0.0136	CbGeAlD
Bromazepam—Ataxia—Procarbazine—brain cancer	0.00375	0.0163	CcSEcCtD
Bromazepam—GABRG3—pituitary gland—brain cancer	0.00371	0.0133	CbGeAlD
Bromazepam—GABRG1—telencephalon—brain cancer	0.00364	0.013	CbGeAlD
Bromazepam—GABRA6—telencephalon—brain cancer	0.00361	0.013	CbGeAlD
Bromazepam—GABRB1—telencephalon—brain cancer	0.00353	0.0127	CbGeAlD
Bromazepam—GABRA5—telencephalon—brain cancer	0.00351	0.0126	CbGeAlD
Bromazepam—Depressed level of consciousness—Carmustine—brain cancer	0.00332	0.0145	CcSEcCtD
Bromazepam—GABRR3—head—brain cancer	0.00324	0.0116	CbGeAlD
Bromazepam—GABRQ—head—brain cancer	0.00324	0.0116	CbGeAlD
Bromazepam—Depressed level of consciousness—Temozolomide—brain cancer	0.00321	0.014	CcSEcCtD
Bromazepam—GABRA4—telencephalon—brain cancer	0.00318	0.0114	CbGeAlD
Bromazepam—Drowsiness—Procarbazine—brain cancer	0.00307	0.0134	CcSEcCtD
Bromazepam—GABRB2—brainstem—brain cancer	0.003	0.0108	CbGeAlD
Bromazepam—GABRD—medulla oblongata—brain cancer	0.00297	0.0107	CbGeAlD
Bromazepam—GABRQ—central nervous system—brain cancer	0.00296	0.0106	CbGeAlD
Bromazepam—Anorexia—Lomustine—brain cancer	0.00294	0.0128	CcSEcCtD
Bromazepam—GABRB1—pituitary gland—brain cancer	0.00287	0.0103	CbGeAlD
Bromazepam—GABRG1—medulla oblongata—brain cancer	0.00286	0.0103	CbGeAlD
Bromazepam—GABRG3—head—brain cancer	0.00284	0.0102	CbGeAlD
Bromazepam—GABRR2—head—brain cancer	0.00281	0.0101	CbGeAlD
Bromazepam—GABRB1—medulla oblongata—brain cancer	0.00277	0.00994	CbGeAlD
Bromazepam—Hallucination—Procarbazine—brain cancer	0.00275	0.012	CcSEcCtD
Bromazepam—GABRA2—brainstem—brain cancer	0.00274	0.00983	CbGeAlD
Bromazepam—GABRD—midbrain—brain cancer	0.00271	0.00973	CbGeAlD
Bromazepam—GABRR1—head—brain cancer	0.00271	0.00971	CbGeAlD
Bromazepam—Decreased appetite—Lomustine—brain cancer	0.00268	0.0117	CcSEcCtD
Bromazepam—GABRG2—telencephalon—brain cancer	0.00266	0.00955	CbGeAlD
Bromazepam—GABRB2—telencephalon—brain cancer	0.00266	0.00955	CbGeAlD
Bromazepam—GABRA1—brainstem—brain cancer	0.00265	0.0095	CbGeAlD
Bromazepam—GABRG1—midbrain—brain cancer	0.00261	0.00937	CbGeAlD
Bromazepam—GABRG3—central nervous system—brain cancer	0.00259	0.0093	CbGeAlD
Bromazepam—GABRA4—pituitary gland—brain cancer	0.00259	0.0093	CbGeAlD
Bromazepam—GABRP—pituitary gland—brain cancer	0.00257	0.00923	CbGeAlD
Bromazepam—GABRG1—spinal cord—brain cancer	0.00255	0.00914	CbGeAlD
Bromazepam—GABRB1—midbrain—brain cancer	0.00253	0.00909	CbGeAlD
Bromazepam—GABRR2—cerebellum—brain cancer	0.00251	0.009	CbGeAlD
Bromazepam—Diplopia—Carmustine—brain cancer	0.0025	0.0109	CcSEcCtD
Bromazepam—GABRR1—central nervous system—brain cancer	0.00247	0.00887	CbGeAlD
Bromazepam—GABRB1—spinal cord—brain cancer	0.00247	0.00886	CbGeAlD
Bromazepam—GABRA2—telencephalon—brain cancer	0.00243	0.00873	CbGeAlD
Bromazepam—Diplopia—Temozolomide—brain cancer	0.00241	0.0105	CcSEcCtD
Bromazepam—Drowsiness—Hydroxyurea—brain cancer	0.00238	0.0104	CcSEcCtD
Bromazepam—Tension—Procarbazine—brain cancer	0.00236	0.0103	CcSEcCtD
Bromazepam—GABRD—head—brain cancer	0.00235	0.00844	CbGeAlD
Bromazepam—GABRQ—brain—brain cancer	0.00235	0.00843	CbGeAlD
Bromazepam—GABRA1—telencephalon—brain cancer	0.00235	0.00843	CbGeAlD
Bromazepam—Ataxia—Carmustine—brain cancer	0.00235	0.0102	CcSEcCtD
Bromazepam—Nervousness—Procarbazine—brain cancer	0.00233	0.0102	CcSEcCtD
Bromazepam—Ataxia—Temozolomide—brain cancer	0.00227	0.00987	CcSEcCtD
Bromazepam—GABRG1—head—brain cancer	0.00226	0.00813	CbGeAlD
Bromazepam—GABRA6—head—brain cancer	0.00225	0.00808	CbGeAlD
Bromazepam—Tremor—Procarbazine—brain cancer	0.00225	0.0098	CcSEcCtD
Bromazepam—Muscular weakness—Carmustine—brain cancer	0.0022	0.00958	CcSEcCtD
Bromazepam—GABRB1—head—brain cancer	0.0022	0.00788	CbGeAlD
Bromazepam—GABRA5—head—brain cancer	0.00218	0.00784	CbGeAlD
Bromazepam—GABRG2—pituitary gland—brain cancer	0.00217	0.00778	CbGeAlD
Bromazepam—GABRD—central nervous system—brain cancer	0.00215	0.0077	CbGeAlD
Bromazepam—Muscular weakness—Temozolomide—brain cancer	0.00213	0.00926	CcSEcCtD
Bromazepam—Hallucination—Hydroxyurea—brain cancer	0.00212	0.00925	CcSEcCtD
Bromazepam—GABRD—cerebellum—brain cancer	0.0021	0.00753	CbGeAlD
Bromazepam—GABRB2—medulla oblongata—brain cancer	0.00209	0.0075	CbGeAlD
Bromazepam—GABRG2—medulla oblongata—brain cancer	0.00209	0.0075	CbGeAlD
Bromazepam—Convulsion—Procarbazine—brain cancer	0.00208	0.00906	CcSEcCtD
Bromazepam—GABRG1—central nervous system—brain cancer	0.00207	0.00742	CbGeAlD
Bromazepam—GABRA3—endocrine gland—brain cancer	0.00206	0.00739	CbGeAlD
Bromazepam—GABRG3—brain—brain cancer	0.00206	0.00739	CbGeAlD
Bromazepam—GABRA6—central nervous system—brain cancer	0.00205	0.00737	CbGeAlD
Bromazepam—GABRB3—telencephalon—brain cancer	0.00204	0.00733	CbGeAlD
Bromazepam—GABRA3—head—brain cancer	0.00203	0.0073	CbGeAlD
Bromazepam—GABRG1—cerebellum—brain cancer	0.00202	0.00725	CbGeAlD
Bromazepam—GABRA6—cerebellum—brain cancer	0.00201	0.00721	CbGeAlD
Bromazepam—GABRB1—central nervous system—brain cancer	0.002	0.00719	CbGeAlD
Bromazepam—Dry mouth—Procarbazine—brain cancer	0.002	0.00871	CcSEcCtD
Bromazepam—GABRA5—central nervous system—brain cancer	0.00199	0.00715	CbGeAlD
Bromazepam—GABRA4—head—brain cancer	0.00198	0.00711	CbGeAlD
Bromazepam—Cardiac failure—Etoposide—brain cancer	0.00198	0.00861	CcSEcCtD
Bromazepam—Confusional state—Procarbazine—brain cancer	0.00198	0.00861	CcSEcCtD
Bromazepam—GABRP—head—brain cancer	0.00197	0.00706	CbGeAlD
Bromazepam—Vomiting—Lomustine—brain cancer	0.00196	0.00855	CcSEcCtD
Bromazepam—GABRE—pituitary gland—brain cancer	0.00196	0.00704	CbGeAlD
Bromazepam—GABRR1—brain—brain cancer	0.00196	0.00704	CbGeAlD
Bromazepam—GABRB1—cerebellum—brain cancer	0.00196	0.00703	CbGeAlD
Bromazepam—Tachycardia—Procarbazine—brain cancer	0.00191	0.00833	CcSEcCtD
Bromazepam—GABRG2—midbrain—brain cancer	0.00191	0.00686	CbGeAlD
Bromazepam—GABRB2—midbrain—brain cancer	0.00191	0.00686	CbGeAlD
Bromazepam—Anorexia—Procarbazine—brain cancer	0.00187	0.00814	CcSEcCtD
Bromazepam—GABRG2—spinal cord—brain cancer	0.00186	0.00669	CbGeAlD
Bromazepam—GABRB2—spinal cord—brain cancer	0.00186	0.00669	CbGeAlD
Bromazepam—GABRA3—central nervous system—brain cancer	0.00186	0.00666	CbGeAlD
Bromazepam—GABRA1—medulla oblongata—brain cancer	0.00185	0.00663	CbGeAlD
Bromazepam—Cardiac arrest—Etoposide—brain cancer	0.00183	0.00799	CcSEcCtD
Bromazepam—Nausea—Lomustine—brain cancer	0.00183	0.00799	CcSEcCtD
Bromazepam—Hypotension—Procarbazine—brain cancer	0.00183	0.00798	CcSEcCtD
Bromazepam—GABRA4—central nervous system—brain cancer	0.00181	0.00649	CbGeAlD
Bromazepam—GABRA4—cerebellum—brain cancer	0.00177	0.00634	CbGeAlD
Bromazepam—Somnolence—Procarbazine—brain cancer	0.00174	0.00759	CcSEcCtD
Bromazepam—Hallucination—Carmustine—brain cancer	0.00172	0.00748	CcSEcCtD
Bromazepam—GABRB3—gonad—brain cancer	0.00171	0.00612	CbGeAlD
Bromazepam—GABRD—brain—brain cancer	0.0017	0.00612	CbGeAlD
Bromazepam—Decreased appetite—Procarbazine—brain cancer	0.0017	0.00742	CcSEcCtD
Bromazepam—Connective tissue disorder—Carmustine—brain cancer	0.0017	0.00739	CcSEcCtD
Bromazepam—Fatigue—Procarbazine—brain cancer	0.00169	0.00736	CcSEcCtD
Bromazepam—GABRA1—midbrain—brain cancer	0.00169	0.00606	CbGeAlD
Bromazepam—GABRB3—pituitary gland—brain cancer	0.00166	0.00597	CbGeAlD
Bromazepam—Hallucination—Temozolomide—brain cancer	0.00166	0.00723	CcSEcCtD
Bromazepam—GABRG2—head—brain cancer	0.00166	0.00595	CbGeAlD
Bromazepam—GABRB2—head—brain cancer	0.00166	0.00595	CbGeAlD
Bromazepam—GABRA1—spinal cord—brain cancer	0.00165	0.00591	CbGeAlD
Bromazepam—GABRG1—brain—brain cancer	0.00164	0.00589	CbGeAlD
Bromazepam—Connective tissue disorder—Temozolomide—brain cancer	0.00164	0.00714	CcSEcCtD
Bromazepam—GABRA6—brain—brain cancer	0.00163	0.00585	CbGeAlD
Bromazepam—Feeling abnormal—Procarbazine—brain cancer	0.00162	0.00703	CcSEcCtD
Bromazepam—Eye disorder—Carmustine—brain cancer	0.00161	0.00702	CcSEcCtD
Bromazepam—Convulsion—Hydroxyurea—brain cancer	0.00161	0.00701	CcSEcCtD
Bromazepam—GABRB3—medulla oblongata—brain cancer	0.00161	0.00576	CbGeAlD
Bromazepam—GABRB1—brain—brain cancer	0.00159	0.00571	CbGeAlD
Bromazepam—GABRA5—brain—brain cancer	0.00158	0.00568	CbGeAlD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00157	0.00684	CcSEcCtD
Bromazepam—Eye disorder—Temozolomide—brain cancer	0.00156	0.00679	CcSEcCtD
Bromazepam—Cardiac disorder—Temozolomide—brain cancer	0.00155	0.00674	CcSEcCtD
Bromazepam—GABRA2—head—brain cancer	0.00151	0.00543	CbGeAlD
Bromazepam—GABRG2—central nervous system—brain cancer	0.00151	0.00543	CbGeAlD
Bromazepam—GABRB2—central nervous system—brain cancer	0.00151	0.00543	CbGeAlD
Bromazepam—Mental disorder—Carmustine—brain cancer	0.00151	0.00659	CcSEcCtD
Bromazepam—Malnutrition—Carmustine—brain cancer	0.0015	0.00654	CcSEcCtD
Bromazepam—GABRE—head—brain cancer	0.0015	0.00539	CbGeAlD
Bromazepam—Nervous system disorder—Hydroxyurea—brain cancer	0.00149	0.00648	CcSEcCtD
Bromazepam—GABRG2—cerebellum—brain cancer	0.00148	0.00531	CbGeAlD
Bromazepam—GABRB2—cerebellum—brain cancer	0.00148	0.00531	CbGeAlD
Bromazepam—Skin disorder—Hydroxyurea—brain cancer	0.00147	0.00642	CcSEcCtD
Bromazepam—GABRA3—brain—brain cancer	0.00147	0.00529	CbGeAlD
Bromazepam—GABRB3—midbrain—brain cancer	0.00147	0.00527	CbGeAlD
Bromazepam—GABRA1—head—brain cancer	0.00146	0.00525	CbGeAlD
Bromazepam—Mental disorder—Temozolomide—brain cancer	0.00146	0.00636	CcSEcCtD
Bromazepam—Malnutrition—Temozolomide—brain cancer	0.00145	0.00632	CcSEcCtD
Bromazepam—Anorexia—Hydroxyurea—brain cancer	0.00145	0.0063	CcSEcCtD
Bromazepam—Hypersensitivity—Procarbazine—brain cancer	0.00144	0.00629	CcSEcCtD
Bromazepam—GABRA4—brain—brain cancer	0.00144	0.00515	CbGeAlD
Bromazepam—GABRB3—spinal cord—brain cancer	0.00143	0.00514	CbGeAlD
Bromazepam—Vision blurred—Carmustine—brain cancer	0.00142	0.00617	CcSEcCtD
Bromazepam—Tremor—Carmustine—brain cancer	0.00141	0.00613	CcSEcCtD
Bromazepam—Asthenia—Procarbazine—brain cancer	0.00141	0.00612	CcSEcCtD
Bromazepam—Pruritus—Procarbazine—brain cancer	0.00139	0.00604	CcSEcCtD
Bromazepam—GABRA2—central nervous system—brain cancer	0.00138	0.00496	CbGeAlD
Bromazepam—Agitation—Carmustine—brain cancer	0.00138	0.00601	CcSEcCtD
Bromazepam—GABRE—central nervous system—brain cancer	0.00137	0.00492	CbGeAlD
Bromazepam—Vision blurred—Temozolomide—brain cancer	0.00137	0.00596	CcSEcCtD
Bromazepam—Tremor—Temozolomide—brain cancer	0.00136	0.00592	CcSEcCtD
Bromazepam—GABRA2—cerebellum—brain cancer	0.00135	0.00485	CbGeAlD
Bromazepam—Somnolence—Hydroxyurea—brain cancer	0.00135	0.00587	CcSEcCtD
Bromazepam—Dyspepsia—Hydroxyurea—brain cancer	0.00134	0.00582	CcSEcCtD
Bromazepam—GABRA1—central nervous system—brain cancer	0.00134	0.00479	CbGeAlD
Bromazepam—Agitation—Temozolomide—brain cancer	0.00133	0.00581	CcSEcCtD
Bromazepam—Decreased appetite—Hydroxyurea—brain cancer	0.00132	0.00574	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00131	0.0057	CcSEcCtD
Bromazepam—Fatigue—Hydroxyurea—brain cancer	0.00131	0.0057	CcSEcCtD
Bromazepam—GABRA1—cerebellum—brain cancer	0.00131	0.00468	CbGeAlD
Bromazepam—Convulsion—Carmustine—brain cancer	0.0013	0.00567	CcSEcCtD
Bromazepam—CYP2E1—telencephalon—brain cancer	0.0013	0.00467	CbGeAlD
Bromazepam—Dizziness—Procarbazine—brain cancer	0.0013	0.00564	CcSEcCtD
Bromazepam—GABRB3—endocrine gland—brain cancer	0.00129	0.00463	CbGeAlD
Bromazepam—Palpitations—Temozolomide—brain cancer	0.00128	0.00559	CcSEcCtD
Bromazepam—GABRB3—head—brain cancer	0.00127	0.00457	CbGeAlD
Bromazepam—Convulsion—Temozolomide—brain cancer	0.00126	0.00548	CcSEcCtD
Bromazepam—Feeling abnormal—Hydroxyurea—brain cancer	0.00125	0.00544	CcSEcCtD
Bromazepam—Eye disorder—Etoposide—brain cancer	0.00125	0.00543	CcSEcCtD
Bromazepam—Vomiting—Procarbazine—brain cancer	0.00125	0.00543	CcSEcCtD
Bromazepam—Cardiac disorder—Etoposide—brain cancer	0.00124	0.00539	CcSEcCtD
Bromazepam—Confusional state—Carmustine—brain cancer	0.00124	0.00538	CcSEcCtD
Bromazepam—Rash—Procarbazine—brain cancer	0.00124	0.00538	CcSEcCtD
Bromazepam—Dermatitis—Procarbazine—brain cancer	0.00123	0.00538	CcSEcCtD
Bromazepam—Headache—Procarbazine—brain cancer	0.00123	0.00535	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00123	0.00535	CcSEcCtD
Bromazepam—Dry mouth—Temozolomide—brain cancer	0.00121	0.00527	CcSEcCtD
Bromazepam—GABRG2—brain—brain cancer	0.0012	0.00431	CbGeAlD
Bromazepam—GABRB2—brain—brain cancer	0.0012	0.00431	CbGeAlD
Bromazepam—Tachycardia—Carmustine—brain cancer	0.0012	0.00521	CcSEcCtD
Bromazepam—Confusional state—Temozolomide—brain cancer	0.0012	0.0052	CcSEcCtD
Bromazepam—Anaphylactic shock—Temozolomide—brain cancer	0.00119	0.00516	CcSEcCtD
Bromazepam—Anorexia—Carmustine—brain cancer	0.00117	0.00509	CcSEcCtD
Bromazepam—Nausea—Procarbazine—brain cancer	0.00116	0.00507	CcSEcCtD
Bromazepam—Nervous system disorder—Temozolomide—brain cancer	0.00116	0.00506	CcSEcCtD
Bromazepam—GABRB3—central nervous system—brain cancer	0.00116	0.00417	CbGeAlD
Bromazepam—Skin disorder—Temozolomide—brain cancer	0.00115	0.00501	CcSEcCtD
Bromazepam—Hypotension—Carmustine—brain cancer	0.00115	0.00499	CcSEcCtD
Bromazepam—GABRB3—cerebellum—brain cancer	0.00114	0.00407	CbGeAlD
Bromazepam—Anorexia—Temozolomide—brain cancer	0.00113	0.00492	CcSEcCtD
Bromazepam—Hypersensitivity—Hydroxyurea—brain cancer	0.00112	0.00487	CcSEcCtD
Bromazepam—Muscle spasms—Etoposide—brain cancer	0.00112	0.00486	CcSEcCtD
Bromazepam—CYP2C19—endocrine gland—brain cancer	0.00112	0.00401	CbGeAlD
Bromazepam—GABRA2—brain—brain cancer	0.0011	0.00394	CbGeAlD
Bromazepam—Somnolence—Carmustine—brain cancer	0.00109	0.00475	CcSEcCtD
Bromazepam—Asthenia—Hydroxyurea—brain cancer	0.00109	0.00474	CcSEcCtD
Bromazepam—GABRE—brain—brain cancer	0.00109	0.0039	CbGeAlD
Bromazepam—Decreased appetite—Carmustine—brain cancer	0.00107	0.00464	CcSEcCtD
Bromazepam—GABRA1—brain—brain cancer	0.00106	0.00381	CbGeAlD
Bromazepam—Gastrointestinal disorder—Carmustine—brain cancer	0.00106	0.00461	CcSEcCtD
Bromazepam—Somnolence—Temozolomide—brain cancer	0.00105	0.00459	CcSEcCtD
Bromazepam—Dyspepsia—Temozolomide—brain cancer	0.00104	0.00454	CcSEcCtD
Bromazepam—Decreased appetite—Temozolomide—brain cancer	0.00103	0.00449	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Temozolomide—brain cancer	0.00102	0.00446	CcSEcCtD
Bromazepam—Fatigue—Temozolomide—brain cancer	0.00102	0.00445	CcSEcCtD
Bromazepam—CYP2E1—medulla oblongata—brain cancer	0.00102	0.00367	CbGeAlD
Bromazepam—Feeling abnormal—Carmustine—brain cancer	0.00101	0.0044	CcSEcCtD
Bromazepam—Convulsion—Etoposide—brain cancer	0.00101	0.00438	CcSEcCtD
Bromazepam—Dizziness—Hydroxyurea—brain cancer	0.001	0.00437	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000983	0.00428	CcSEcCtD
Bromazepam—Feeling abnormal—Temozolomide—brain cancer	0.000977	0.00425	CcSEcCtD
Bromazepam—Vomiting—Hydroxyurea—brain cancer	0.000965	0.0042	CcSEcCtD
Bromazepam—Rash—Hydroxyurea—brain cancer	0.000957	0.00417	CcSEcCtD
Bromazepam—Confusional state—Etoposide—brain cancer	0.000956	0.00416	CcSEcCtD
Bromazepam—Dermatitis—Hydroxyurea—brain cancer	0.000956	0.00416	CcSEcCtD
Bromazepam—Headache—Hydroxyurea—brain cancer	0.00095	0.00414	CcSEcCtD
Bromazepam—Anaphylactic shock—Etoposide—brain cancer	0.000948	0.00413	CcSEcCtD
Bromazepam—Tachycardia—Etoposide—brain cancer	0.000926	0.00403	CcSEcCtD
Bromazepam—GABRB3—brain—brain cancer	0.000922	0.00331	CbGeAlD
Bromazepam—Skin disorder—Etoposide—brain cancer	0.000921	0.00401	CcSEcCtD
Bromazepam—CYP1A2—endocrine gland—brain cancer	0.000912	0.00327	CbGeAlD
Bromazepam—CYP2E1—spinal cord—brain cancer	0.000911	0.00327	CbGeAlD
Bromazepam—Anorexia—Etoposide—brain cancer	0.000904	0.00394	CcSEcCtD
Bromazepam—Hypersensitivity—Carmustine—brain cancer	0.000904	0.00393	CcSEcCtD
Bromazepam—Nausea—Hydroxyurea—brain cancer	0.000901	0.00392	CcSEcCtD
Bromazepam—Hypotension—Etoposide—brain cancer	0.000886	0.00386	CcSEcCtD
Bromazepam—Asthenia—Carmustine—brain cancer	0.00088	0.00383	CcSEcCtD
Bromazepam—Hypersensitivity—Temozolomide—brain cancer	0.000873	0.0038	CcSEcCtD
Bromazepam—Asthenia—Temozolomide—brain cancer	0.00085	0.0037	CcSEcCtD
Bromazepam—Somnolence—Etoposide—brain cancer	0.000843	0.00367	CcSEcCtD
Bromazepam—Pruritus—Temozolomide—brain cancer	0.000839	0.00365	CcSEcCtD
Bromazepam—Decreased appetite—Etoposide—brain cancer	0.000824	0.00359	CcSEcCtD
Bromazepam—CYP2E1—endocrine gland—brain cancer	0.00082	0.00294	CbGeAlD
Bromazepam—Gastrointestinal disorder—Etoposide—brain cancer	0.000819	0.00357	CcSEcCtD
Bromazepam—Fatigue—Etoposide—brain cancer	0.000818	0.00356	CcSEcCtD
Bromazepam—Dizziness—Carmustine—brain cancer	0.000811	0.00353	CcSEcCtD
Bromazepam—CYP2E1—head—brain cancer	0.00081	0.00291	CbGeAlD
Bromazepam—Dizziness—Temozolomide—brain cancer	0.000784	0.00341	CcSEcCtD
Bromazepam—Feeling abnormal—Etoposide—brain cancer	0.000782	0.0034	CcSEcCtD
Bromazepam—Vomiting—Carmustine—brain cancer	0.00078	0.0034	CcSEcCtD
Bromazepam—Rash—Carmustine—brain cancer	0.000773	0.00337	CcSEcCtD
Bromazepam—Dermatitis—Carmustine—brain cancer	0.000773	0.00336	CcSEcCtD
Bromazepam—Headache—Carmustine—brain cancer	0.000768	0.00335	CcSEcCtD
Bromazepam—Vomiting—Temozolomide—brain cancer	0.000754	0.00328	CcSEcCtD
Bromazepam—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.000753	0.0425	CbGpPWpGaD
Bromazepam—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00075	0.0423	CbGpPWpGaD
Bromazepam—Rash—Temozolomide—brain cancer	0.000747	0.00325	CcSEcCtD
Bromazepam—Dermatitis—Temozolomide—brain cancer	0.000747	0.00325	CcSEcCtD
Bromazepam—Headache—Temozolomide—brain cancer	0.000743	0.00323	CcSEcCtD
Bromazepam—CYP2E1—central nervous system—brain cancer	0.000739	0.00265	CbGeAlD
Bromazepam—Nausea—Carmustine—brain cancer	0.000729	0.00317	CcSEcCtD
Bromazepam—CYP2E1—cerebellum—brain cancer	0.000722	0.00259	CbGeAlD
Bromazepam—Nausea—Temozolomide—brain cancer	0.000704	0.00307	CcSEcCtD
Bromazepam—Hypersensitivity—Etoposide—brain cancer	0.000699	0.00304	CcSEcCtD
Bromazepam—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000682	0.0385	CbGpPWpGaD
Bromazepam—Asthenia—Etoposide—brain cancer	0.00068	0.00296	CcSEcCtD
Bromazepam—Pruritus—Etoposide—brain cancer	0.000671	0.00292	CcSEcCtD
Bromazepam—CYP3A4—endocrine gland—brain cancer	0.00066	0.00237	CbGeAlD
Bromazepam—Dizziness—Etoposide—brain cancer	0.000627	0.00273	CcSEcCtD
Bromazepam—Vomiting—Etoposide—brain cancer	0.000603	0.00263	CcSEcCtD
Bromazepam—Rash—Etoposide—brain cancer	0.000598	0.0026	CcSEcCtD
Bromazepam—Dermatitis—Etoposide—brain cancer	0.000597	0.0026	CcSEcCtD
Bromazepam—CYP3A4—central nervous system—brain cancer	0.000595	0.00213	CbGeAlD
Bromazepam—Headache—Etoposide—brain cancer	0.000594	0.00259	CcSEcCtD
Bromazepam—CYP2E1—brain—brain cancer	0.000587	0.00211	CbGeAlD
Bromazepam—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000584	0.033	CbGpPWpGaD
Bromazepam—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000581	0.0328	CbGpPWpGaD
Bromazepam—Nausea—Etoposide—brain cancer	0.000563	0.00245	CcSEcCtD
Bromazepam—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000532	0.03	CbGpPWpGaD
Bromazepam—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000467	0.0264	CbGpPWpGaD
Bromazepam—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000449	0.0254	CbGpPWpGaD
Bromazepam—GABRQ—Orphan transporters—S100A10—brain cancer	0.000408	0.0231	CbGpPWpGaD
Bromazepam—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00036	0.0203	CbGpPWpGaD
Bromazepam—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000346	0.0196	CbGpPWpGaD
Bromazepam—GABRG3—Orphan transporters—S100A10—brain cancer	0.000336	0.019	CbGpPWpGaD
Bromazepam—GABRB1—Orphan transporters—S100A10—brain cancer	0.000331	0.0187	CbGpPWpGaD
Bromazepam—GABRA6—Orphan transporters—S100A10—brain cancer	0.000313	0.0177	CbGpPWpGaD
Bromazepam—GABRA4—Orphan transporters—S100A10—brain cancer	0.000309	0.0175	CbGpPWpGaD
Bromazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000305	0.0172	CbGpPWpGaD
Bromazepam—GABRB2—Orphan transporters—S100A10—brain cancer	0.000283	0.016	CbGpPWpGaD
Bromazepam—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000281	0.0159	CbGpPWpGaD
Bromazepam—GABRA5—Orphan transporters—S100A10—brain cancer	0.000275	0.0155	CbGpPWpGaD
Bromazepam—GABRA3—Orphan transporters—S100A10—brain cancer	0.00027	0.0152	CbGpPWpGaD
Bromazepam—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00027	0.0152	CbGpPWpGaD
Bromazepam—GABRA2—Orphan transporters—S100A10—brain cancer	0.000265	0.015	CbGpPWpGaD
Bromazepam—GABRB3—Orphan transporters—S100A10—brain cancer	0.000264	0.0149	CbGpPWpGaD
Bromazepam—GABRG2—Orphan transporters—S100A10—brain cancer	0.000259	0.0146	CbGpPWpGaD
Bromazepam—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000247	0.014	CbGpPWpGaD
Bromazepam—GABRA1—Orphan transporters—S100A10—brain cancer	0.000226	0.0128	CbGpPWpGaD
Bromazepam—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000217	0.0122	CbGpPWpGaD
Bromazepam—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000208	0.0118	CbGpPWpGaD
Bromazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000194	0.0109	CbGpPWpGaD
Bromazepam—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000191	0.0108	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—NTRK3—brain cancer	0.000189	0.0107	CbGpPWpGaD
Bromazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000184	0.0104	CbGpPWpGaD
Bromazepam—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000173	0.00977	CbGpPWpGaD
Bromazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000157	0.00888	CbGpPWpGaD
Bromazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00015	0.00845	CbGpPWpGaD
Bromazepam—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000149	0.0084	CbGpPWpGaD
Bromazepam—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000148	0.00834	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000147	0.00832	CbGpPWpGaD
Bromazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000142	0.008	CbGpPWpGaD
Bromazepam—GABRR1—Ion channel transport—TRPC6—brain cancer	0.000139	0.00783	CbGpPWpGaD
Bromazepam—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000135	0.00762	CbGpPWpGaD
Bromazepam—GABRR2—Ion channel transport—TRPC6—brain cancer	0.000132	0.00747	CbGpPWpGaD
Bromazepam—GABRQ—Ion channel transport—TRPC6—brain cancer	0.000132	0.00747	CbGpPWpGaD
Bromazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000121	0.00685	CbGpPWpGaD
Bromazepam—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000117	0.00658	CbGpPWpGaD
Bromazepam—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000115	0.0065	CbGpPWpGaD
Bromazepam—GABRG3—Ion channel transport—TRPC6—brain cancer	0.000109	0.00615	CbGpPWpGaD
Bromazepam—GABRB1—Ion channel transport—TRPC6—brain cancer	0.000107	0.00606	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000104	0.0059	CbGpPWpGaD
Bromazepam—GABRA6—Ion channel transport—TRPC6—brain cancer	0.000102	0.00573	CbGpPWpGaD
Bromazepam—GABRA4—Ion channel transport—TRPC6—brain cancer	0.0001	0.00566	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—S100A10—brain cancer	9.97e-05	0.00563	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—S100A10—brain cancer	9.97e-05	0.00563	CbGpPWpGaD
Bromazepam—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.45e-05	0.00534	CbGpPWpGaD
Bromazepam—GABRB2—Ion channel transport—TRPC6—brain cancer	9.17e-05	0.00518	CbGpPWpGaD
Bromazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	8.99e-05	0.00508	CbGpPWpGaD
Bromazepam—GABRA5—Ion channel transport—TRPC6—brain cancer	8.9e-05	0.00503	CbGpPWpGaD
Bromazepam—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	8.88e-05	0.00501	CbGpPWpGaD
Bromazepam—GABRA3—Ion channel transport—TRPC6—brain cancer	8.74e-05	0.00494	CbGpPWpGaD
Bromazepam—GABRA2—Ion channel transport—TRPC6—brain cancer	8.59e-05	0.00485	CbGpPWpGaD
Bromazepam—GABRB3—Ion channel transport—TRPC6—brain cancer	8.54e-05	0.00482	CbGpPWpGaD
Bromazepam—GABRG2—Ion channel transport—TRPC6—brain cancer	8.38e-05	0.00474	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—CYP2C9—brain cancer	8.35e-05	0.00471	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	8.23e-05	0.00465	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—S100A10—brain cancer	8.21e-05	0.00464	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—S100A10—brain cancer	8.08e-05	0.00457	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—S100A10—brain cancer	7.65e-05	0.00432	CbGpPWpGaD
Bromazepam—CYP3A4—Irinotecan Pathway—APC—brain cancer	7.64e-05	0.00431	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—S100A10—brain cancer	7.55e-05	0.00427	CbGpPWpGaD
Bromazepam—GABRA1—Ion channel transport—TRPC6—brain cancer	7.33e-05	0.00414	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	7.29e-05	0.00412	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—S100A10—brain cancer	6.91e-05	0.0039	CbGpPWpGaD
Bromazepam—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	6.77e-05	0.00383	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—S100A10—brain cancer	6.71e-05	0.00379	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—S100A10—brain cancer	6.59e-05	0.00372	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—S100A10—brain cancer	6.48e-05	0.00366	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP2C9—brain cancer	6.44e-05	0.00364	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—S100A10—brain cancer	6.43e-05	0.00363	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	6.35e-05	0.00359	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—S100A10—brain cancer	6.32e-05	0.00357	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—ESR2—brain cancer	6.27e-05	0.00354	CbGpPWpGaD
Bromazepam—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	6.22e-05	0.00351	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—SPP1—brain cancer	5.59e-05	0.00316	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—S100A10—brain cancer	5.52e-05	0.00312	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	5.18e-05	0.00292	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—IRS2—brain cancer	5.05e-05	0.00285	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—CYP2C9—brain cancer	5.02e-05	0.00283	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	4.95e-05	0.0028	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—HES1—brain cancer	4.87e-05	0.00275	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.82e-05	0.00272	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.6e-05	0.0026	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—TRPC6—brain cancer	4.6e-05	0.0026	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—APC—brain cancer	4.46e-05	0.00252	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.87e-05	0.00219	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.82e-05	0.00216	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.79e-05	0.00214	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.73e-05	0.00211	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—TRPC6—brain cancer	3.53e-05	0.002	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—TRPC6—brain cancer	3.49e-05	0.00197	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—RELA—brain cancer	3.49e-05	0.00197	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.19e-05	0.0018	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—TRPC6—brain cancer	3.1e-05	0.00175	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.04e-05	0.00172	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—CTNNB1—brain cancer	3.03e-05	0.00171	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.99e-05	0.00169	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	2.99e-05	0.00169	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—TRPC6—brain cancer	2.97e-05	0.00168	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.92e-05	0.00165	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	2.69e-05	0.00152	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—STAT3—brain cancer	2.64e-05	0.00149	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.55e-05	0.00144	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.47e-05	0.0014	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	2.44e-05	0.00138	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.29e-05	0.00129	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.15e-05	0.00121	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.1e-05	0.00119	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.06e-05	0.00116	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.06e-05	0.00116	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.93e-05	0.00109	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.81e-05	0.00102	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP2C9—brain cancer	1.43e-05	0.000806	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.41e-05	0.000796	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—BSG—brain cancer	1.21e-05	0.000686	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP2C9—brain cancer	1.1e-05	0.000622	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—IDH1—brain cancer	1.04e-05	0.00059	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—BSG—brain cancer	9.37e-06	0.000529	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP2C9—brain cancer	8.58e-06	0.000485	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ENO2—brain cancer	8.25e-06	0.000466	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—IDH1—brain cancer	8.05e-06	0.000455	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—BSG—brain cancer	7.3e-06	0.000412	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP2C9—brain cancer	6.62e-06	0.000374	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.56e-06	0.00037	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ENO2—brain cancer	6.37e-06	0.00036	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—IDH1—brain cancer	6.28e-06	0.000354	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—BSG—brain cancer	5.63e-06	0.000318	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.11e-06	0.000289	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ENO2—brain cancer	4.96e-06	0.00028	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—IDH1—brain cancer	4.84e-06	0.000274	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ENO2—brain cancer	3.83e-06	0.000216	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PIK3CG—brain cancer	3.79e-06	0.000214	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PIK3CG—brain cancer	2.92e-06	0.000165	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PIK3CG—brain cancer	2.28e-06	0.000129	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PIK3CG—brain cancer	1.76e-06	9.92e-05	CbGpPWpGaD
